Ascension Saint Clare's Hospital

Weston, Wisconsin 54476

0 studies enrolling now · 3 studies all time

What they study most

HER2-Positive Breast Carcinoma, HER2/Neu Positive, Hormone Receptor-Positive Breast Carcinoma, Pancreatic Adenocarcinoma, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Resectable Pancreatic Carcinoma, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7

Studies at this site

• Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer — Completed
• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer — Completed
• S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery — Completed